| Patient | Sex | Age | Tumor Entity | Sample | Collection Site | Laboratory |
| A.B. | f | 50 | Mamma Ca. | FFPE | mamma | Agendia |
| K.B. | f | 65 | Mamma Ca. | FFPE | mamma | Agendia |
| G.H. | f | 29 | Mamma Ca. | FFPE | mamma | Neoscreen |
| N.Bi. | f | 60 | Mamma Ca. ( invasive lobular ca. grade III) | FFPE | mamma | Oncotype |
| M.S. | f | 67 | Mamma High-Grade Ca. | FFPE | axillar lymph node | Oncotype |
| J.D. | f | 38 | Mamma Ca. (liver metastasis) | FFPE | liver | Paradigm |
| N.Ba. | f | 36 | Mamma Ca. | FFPE | mamma | Omicure |
| M.A.H.* | m | 72 | Lung Cancer | blood | peripheral blood | Omicure |
| Z.Z. | f | 54 | NSCLC (brain metastasis) | blood | peripheral blood | Omicure |
| S.L. | m | 68 | NSCLC | FFPE | lung | Oncotype |
| A.A.R. | m | 78 | Adenocarcinoma of the Lung | blood | peripheral blood | Omicure |
| S.Y. | f | 63 | Sqamous Cell Ca. | FFPE | nasopharynx | Oncotype |
| M.Sh. | m | 25 | Malignant Neoplasm | FFPE | nasopharynx | Oncotype |
| M.H. | m | 42 | Naso-pharyngal Undifferentiated Ca | FFPE | nasopharynx | Omicure |
| A.G. | m | 63 | Hepatocellular Ca. | FFPE | liver | Oncotype |
| M.A. | m | 71 | Intrahepatic Cholangiocarcinoma | FFPE | liver | Oncotype |
| W.M. | f | 48 | Spindle Cell Sarcoma | FFPE | left upper arm | Oncotype |
| M.K. | m | 77 | Sarcoma | FFPE | left arm | Omicure |
| S.T. | f | 63 | Thyroid Cancer, Papillary Ca. | FFPE | thyroid | Omicure |
| F.M. | f | 63 | Colorectal Adenocarcinoma | FFPE | colon | Oncotype |
| L.H. | f | 56 | Ovarian Ca. (serous high grade) | blood | peripheral blood | Omicure |
| S.A. | m | 36 | Gastric Cancer | blood | peripheral blood | Omicure |
| M.Ka. | m | 71 | Bladder Transitional Cell Ca. | FFPE | bladder | Omicure |